Gilead Sciences Inc (GILD)

[LongRun8]

http://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/209531Orig1s000Approv.pdf

Quote from page 5 of the PDF file in the link above:

This voucher entitles you to designate a single human drug application submitted under section 505(b)(l) of the FDCA or a single biologic application submitted under section 351 of the Public Health Service Act as qualifying for a priority review. Such an application would not have to meet any other requirements for a priority review.

The bottommost sentence is the the key one. I would try to add emphasis, but I can't bold it through my phone.